Control of Therapy of Acne Papulopustulosa by Visible Light With Waterfiltered Infrared and / or Adapalen (Differin Gel)
NCT ID: NCT00237978
Last Updated: 2009-05-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
60 participants
INTERVENTIONAL
2006-09-30
2009-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study for Long-term Treatment of Acne Vulgaris With Skinoren Versus Differin
NCT01387048
A Study Comparing Adapalene Gel 0.1% and to Differin Gel in the Treatment of Acne Vulgaris
NCT04797793
Study Comparing Adapalene Gel 0.3% to Differin® and Both to a Placebo Control in Treatment of Acne Vulgaris
NCT02411942
Assessment of Subjects' Efficacy and Experiences Using Adapalene BPO Gel in the Treatment of Acne Vulgaris
NCT01209949
Photodynamic Therapy of Actinic Keratosis of the Face and Scalp With and Without Prior Curettage
NCT03697590
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
VIS and wIRA
VIS and wIRA
2
VIS, wIRA and Adapalen
Adapalen
VIS and wIRA
3
Adapalen
Adapalen
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Adapalen
VIS and wIRA
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* At least 5 inflammatory and 5 non-inflammatory lesions in the face
* Age \>= 14 years
Exclusion Criteria
* Antiandrogen therapy
* therapy with antibiotics within the last 4 weeks
* therapy with retinoids within the last 6 months
* natural or artificial UV-therapy within the last 4 weeks
* severe acne papulopustulosa according to Burton Scale 5 or 6
* Severe systemic condition
* Secondary acne
14 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Technische Universität Dresden
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Technical University Dresden
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Roland Aschoff, MD
Role: PRINCIPAL_INVESTIGATOR
Technische Universität Dresden, Fetscher Str. 74, 01307 Dresden, Germany
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden
Dresden, Saxony, Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TUD-Akne02-003
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.